Necrosis Recruiting Phase 2 Trials for Methylprednisolone (DB00959)

Also known as: Necrotic / Necrosis NOS

IndicationStatusPhase
DBCOND0012371 (Necrosis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs